The expression of the indicator of T cell mid activation, inducible costimulatory molecule (ICOS), has been reported to be enhanced both in CLA+ and CLA− memory T cell subsets in patients with AD compared to HC and patients with PSO, predominantly in the skin-homing subset, and correlates with SCORAD. The gene discussed is SELPLG; the disease is Alzheimer disease.